TS
TWST icon

Triglav Skladi’s Twist Bioscience TWST Stock Holding History

Triglav Skladi’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.81M Buy
+17,615
New +$1.15M 0.1% 110

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Triglav Skladi's TWST Position: Q2 2026 in Review

Triglav Skladi opened a new position in Twist Bioscience (TWST) in Q2 2026: 17,615 shares worth $1.81M. The stake represents 0.1% of the portfolio and ranks #110 among its holdings.

335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Triglav Skladi held 17,615 shares of Twist Bioscience worth $1.81M as of Q2 2026.
  • Twist Bioscience was a new Triglav Skladi position in Q2 2026.
  • Twist Bioscience made up 0.1% of Triglav Skladi's portfolio in Q2 2026, its #110 holding.
  • 335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Triglav Skladi's 13F filing for Q2 2026, filed 11 Aug 2026.